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ABERRANT EXPRESSION PATTERN OF THE SS-B/La ANTIGEN 
IN THE LABIAL SALIVARY GLANDS OF PATIENTS
•  •
WITH SJOGREN’S SYNDROME
P. C. M. d e  WILDE, L. KATER, C. BODEUTSCH, F. H. J. v a n  d e n  HOOGEN,
L. B. A. v a n  d e  PUTTE, and W. J. v a n  VENROOIJ
Objective. Salivary glands of patients with Sjo­
gren’s syndrome (SS) have been shown to be a site of 
anti-SS-B/La antibody production. The present study 
investigated differences in the localization of the SS- 
B/La antigen in labial salivary gland (LSG) tissue be­
tween SS and non-SS patients, which may explain the 
local antigen-driven anti-SS-B/La response.
Methods. Distribution of SS-B/La was studied 
immunohistologically in the LSG biopsy samples of 9 SS 
patients, 10 non-SS patients, and in normal tissues 
obtained at autopsy within 2 hours after death, using a 
mouse monoclonal antibody directed to SS-B/La. In 3 SS 
and 3 non-SS patients, LSGs were also studied with 
affinity-purified biotinylated human antibodies directed 
against SS-B/La.
Results. In the non-SS patients, SS-B/La was 
primarily observed in the nucleoli of acinic cells of the 
LSGs. Patients with either primary SS or secondary SS 
showed an accumulation of SS-B/La in the nucleoplasm 
of acinic cells. In the SS patients, SS-B/La was also 
detected in the cytoplasm as a diffuse or perinuclear 
staining. Sometimes, SS-B/La was found along the mem­
brane of acinic cells as well. This aberrant nuclear and 
cytoplasmic distribution of SS-B/La in SS patients cor­
related well with abnormalities in the composition of the 
plasma cell population in the LSGs, but not with a 
lymphocytic focus score >1.
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Conclusion. The accumulation and redistribution 
of SS-B/La in the LSGs may play an important role in 
the local antigen-driven anti-SS-B/La response in SS, 
and can also be used to improve the diagnostic possibil­
ities of the LSG biopsy.
Antibodies against SS-B/La and SS-A/Ro RNPs 
are often found in the serum of patients with Sjogren’s 
syndrome (SS) (1-5). Although such autoantibodies 
are not disease-specific for SS (they can also be found 
in other autoimmune diseases), their presence has 
been included as a diagnostic parameter in the Califor­
nia criteria and the preliminary European criteria for 
the classification of SS (6,7).
SS-B/La is a 47-kd polypeptide associated with 
small RNA molecules in RNP complexes (1,2). The 
antigen is located in the nucleus and, to a lesser extent, 
in the cytoplasm of cells (2). The SS-A/Ro RNPs 
comprise SS-A/Ro proteins complexed with a subset 
of SS-B/La-associated RNAs, known as the RNA 
polymerase Ill-transcribed Y RNAs (2,3).
It is well known that exocrine tissues are a site 
of B cell activation and autoantibody production in SS 
(8-10). Patients with SS show increased numbers of 
IgG- and IgM-containing plasma cells in their labial 
salivary gland (LSG) tissue (11-14). Anti-SS-B/La 
antibodies have been demonstrated in the cytoplasm 
of plasma cells in the LSGs of SS patients (10). Saliva 
in these patients is enriched with anti-SS-B/La anti­
bodies, as compared with the serum, and these anti­
bodies have been found in the saliva of SS patients 
without detectable anti-SS-B/La activity in the serum 
(15). These findings point to the possibility that anti- 
SS-B/La antibodies are produced and secreted in the 
salivary glands of SS patients. However, it is unclear 
whether the SS-B/La antigen and anti-SS-B/La anti­
bodies play a role in the pathogenesis of SS.
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Table 1. Clinical features and histologic, immunohistologic, and serologic findings in the patients studied*
Patient Diagnosis Xero
Labial salivary glands Serum
KCS LFS % IgA DF score SW5 Hum- a-La Anti-SS-B/La
1 Prim SS 4* + 5.1 19 -9 .6 A ND —
2 Prim SS + + 2.1 39 -6.1 A ND
3 Prim SS — — 2.7 57 -3 .6 A ND —
4 Sec SS + RA — + 1.7 68 -2 .2 A ND —
5 Sec SS + RA + 2.9 31 -5 .8 A ND —
6 Sec SS + SSc + + 3.2 67 -1 .0 A ND —
7 RA — + 1.2 75 -1.1 N ND —
8 RA — — 1.7 88 0.3 N ND ■MMI
9 No CTD + ND 0 93 0.9 N ND ND
10 No CTD mutum 0.2 95 1.2 N ND 4“
11 No CTD — 4- 0 78 -1 .4 N ND ND
12 No CTD — — 0.9 82 -0 .3 N ND —
13 No CTD — + 0 94 1.0 N ND —
14 Prim SS + — 2.3 49 -5 .2 A A +
15 Prim SS — — 12 13 -9 .2 A ■ A +
16 Prim SS + + 1.5 64 -1 .8 A A +
17 No CTD + 0 95 1.2 N N —
18 No CTD ■ |w 0 97 1.5 N N —
19 No CTD H* + 0 98 1.5 N N —
* Xero = xerostomia; KCS = keratoconjunctivitis sicca, after ophthalmologic examination; LFS = lymphocytic focus score; % IgA = 
percentage IgA-containing plasma cells; DF score = discriminant function score ([0.062 x % IgA] -  4.387); SW5 = mouse monoclonal antibody 
directed against SS-B/La; Hum-a-La = affinity-purified, biotinylated human antibody against SS-B/La; prim SS = primary Sjogren’s syndrome; 
A = aberrant immunostaining pattern of the SS-B/La antigen in acinic cells; ND = not done; sec SS = secondary Sjogren’s syndrome; RA = 
rheumatoid arthritis; SSc = systemic sclerosis; N = normal immunostaining pattern; CTD = connective tissue disease.
In the present study, the immunostaining pat­
tern of SS-B/La in the LSGs of SS patients was 
compared with that in non-SS patients. Furthermore, 
the distribution of SS-B/La in various normal tissues 
was studied. The aim of this study was to search for 
differences in the expression pattern of SS-B/La be­
tween SS and non-SS patients, which might be related 
to the local production and secretion of antibodies to 
these antigens. In addition, the relationship between 
the SS-B/La immunostaining pattern and the compo­
sition of Ig-containing plasma cells in LSG tissue was 
studied.
PATIENTS AND METHODS
Patients. LSG biopsy samples were obtained from 9 
SS patients, 6 with primary SS and 3 with secondary SS (2 
associated with rheumatoid arthritis [RA] and 1 associated 
with systemic sclerosis). Informed consent was obtained in 
all cases. Six of the 9 SS patients fulfilled the criteria for the 
classification of SS as described by Daniels and Talal (16). In 
3 patients, keratoconjunctivitis sicca (KCS) was absent; 
however, these patients had a lymphocytic focus score >1 
and serologic abnormalities compatible with a diagnosis of 
“possible SS,” according to the criteria of Daniels and Talal 
(16). Two of these 3 patients had elevated levels of IgG and 
rheumatoid factor, antinuclear antibodies, and antibodies
against SS-A/Ro and SS-B/La in their serum (patients 3 and 
15 in Table 1). In addition, the 3 patients had an abnormal 
composition of the plasmacellular infiltrate consistent with a
diagnosis of SS (Table 1).
As controls, LSG biopsy samples from 10 non-SS 
patients were used: 2 from RA patients without any clinical 
evidence of SS who voluntarily underwent lip biopsy, and 8 
from patients without SS who underwent an LSG biopsy 
procedure for diagnostic purposes. Among the latter group, 
3 patients who had KCS and xerostomia but did not show 
any other clinical, serologic, or histopathologic evidence of 
SS were included as controls (Table 1).
For diagnosis of SS via the LSG biopsy, a part of the 
biopsy specimen was fixed in a formol sublimate solution 
(17,18). The lymphocytic focus scores (19) were determined 
from hematoxylin and eosin-stained sections. The percent­
ages of IgA-, IgG-, and IgM-containing plasma cells were 
determined according to a procedure which has been de­
scribed in detail previously (12,18). Briefly, a percentage of 
IgA-containing plasma cells <70%, and/or a discriminant 
function (DF) score (DF = [0.062 x %  IgA] -  [0.088 x %
IgG] 4.387) of lower than -2 was considered to be
diagnostic for SS in the LSG biopsy (14). Because of the 
very high sensitivities (95%) and specificities (95%) of these 
immunohistologic criteria (14), we included the 3 patients 
with “possible SS” in the group of patients with primary SS.
Primary antisera. In this study, the following primary 
antisera were used to assess the differences in immunoreac- 
tivity of SS-B/La in the LSGs of the SS and non-SS patients,
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La, obtained from an SS patient, were purified by affinity 
chromotography (28), and subsequently biotinylated accord­
ing to a published protocol (29).
Immunohistochemical analysis. LSGs were snap fro­
zen in liquid nitrogen, and 5~nm sections were cut, air-dried 
overnight, fixed in acetone for 10 minutes, and rinsed in 
phosphate buffered saline (PBS) (3 washes of 5 minutes 
each).
MAb SW5, 2.73, 4G3, and Y12 were used in an 
indirect immunoperoxidase (IP) technique. Incubations were 
performed with MAb SW5 (at 1:80 dilution for 60 minutes), 
with MAb 2.73 and 4G3 (at 1:100 dilution for 60 minutes), 
and with the MAb Y12 (at 1:10 dilution for 60 minutes), 
followed by incubation with peroxidase-labeled rabbit 
anti-mouse serum (at 1:80 dilution for 30 minutes).
To visualize SS-A/Ro with MAb 2G10, a 3-step 
indirect IP technique with undiluted MAb appeared to be 
necessary. This was subsequently incubated with peroxidase- 
labeled rabbit anti-mouse serum (at 1:80 dilution for 30 
minutes) and peroxidase-labeled swine anti-rabbit serum (at 
1:100 dilution for 30 minutes).
To visualize SS-B/La with the affinity-purified, bio­
tinylated human anti-SS-B/La, the following protocol was 
used: endogenous biotin and avidin were blocked using an 
avidin-biotin blocking kit (Vector Laboratories * Burlingame, 
CA), followed by rinsing 3 times in PBS and incubations with 
biotinylated primary antibody (1:80 dilution, overnight at 
4°C), mouse anti-biotin (1:50 dilution for 30 minutes), bio­
tinylated horse anti-mouse (1:200 dilution foi* 30 minutes), 
and peroxidase-labeled avidin-biotin complex (1:100 dilution 
for 30 minutes).
All antisera were diluted in PBS (pH 7.4) containing 
1% bovine serum albumin. The incubations were performed 
at room temperature and followed by 3 washes in PBS of 5 
minutes each, unless otherwise noted. Peroxidase was de­
veloped with diaminobenzidine and hydrogen peroxide for 5 
minutes, and intensified with 0.5% CuS04 for 1 minute. In 
the control sections, incubation with the primary antibodies 
was replaced by incubation with only PBS. No nuclear or 
cytoplasmic counterstaining was used, in order to facilitate 
the microscopic assessment of the antigen expression pat­
tern. Titration experiments with the primary antibodies were 
performed in order to determine the optimal concentrations 
and to obtain semiquantitative information about possible 
differences in the amount of antigens between SS and 
non-SS patients.
To study the SS-B/La distribution in normal tissues, 
specimens of liver, spleen, pancreas, adrenal gland, lymph 
nodes, striated muscle, and duodenum, obtained from 3 
patients at autopsy within 2 hours postmortem, were used. 
The cause of death was cerebral hemorrhage, and none of 
these patients was known to have a systemic autoimmune 
disease. Frozen sections of these tissue specimens were 
stained with MAb SW5, according to the IP technique as 
described above.
RESULTS
The most striking difference between SS and 
non-SS patients was the very intense SS-B/La immuno- 
staining of the nucleoplasm in the majority of acinic
cells in all SS patients. In non-SS patients, the immuno- 
staining was limited to the nucleoli of acinic cells, 
whereas the nucleoplasm was negative or very weakly 
stained. Figures 1A and B demonstrate the difference 
in the SS-B/La immunoreactivity between a patient 
with primary SS and a non-SS patient, using MAb 
SW5. The nuclear staining results with MAb SW5 and 
with the biotinylated human polyclonal anti-SS-B/La 
were essentially the same (Figures 1C and D). There 
was no difference between primary SS and secondary 
SS with regard to the SS-B/La nuclear immunoreac­
tivity (Figures IA and E). The expression patterns of 
SS-B/La in the LSG biopsy samples of both of the RA 
patients without any evidence of SS (Figure IF) and 
the control subjects without any systemic connective 
tissue disease (Figure IB) were essentially the same.
With regard to localization of U1 snRNP, U2 
snRNP, and Sm, no differences between SS and 
non-SS patients were found. In all patients, there was 
high nucleoplasmic staining for these spliceosome- 
related antigens (Figures 2A-D). No obvious quanti­
tative differences between SS and non-SS patients 
were observed in titration experiments (data not 
shown).
The 3-step indirect IP technique to visualize 
SS-A/Ro resulted in a very high background, which 
hampered the interpretation of staining results. In the 
acinic cells of SS and non-SS patients, both stained 
and nonstained nuclei were observed; however, in SS 
patients, the staining intensity and the fraction of 
positive nuclei seemed to be higher than in non-SS 
patients (Figures 2E and F). In some acinic cells of the 
non-SS patients, SS-A/Ro was found in the nucleoli, 
while in other acinic cells of the same patient, it was 
observed in the nucleoplasm (Figure 2F). The differ­
ences for expression of SS-A/Ro between SS and 
non-SS patients were obviously less convincing than 
those of SS-B/La.
At a higher magnification (x 1,000), the nuclear 
staining pattern of SS-B/La in the acinic cells of SS 
patients appeared to be speckled (Figure 3A). In SS 
patients, SS-B/La was also observed in the cytoplasm 
of some acinic cells in a perinuclear or diffuse granular 
pattern, or along the membrane of these cells. In such 
acinic cells, a decrease or even absence of nuclear 
SS-B/La was noted (Figure 3B). In the non-SS pa­
tients, no cytoplasmic SS-B/La was observed in the 
LSG tissue. At higher magnification, U1 snRNP, U2 
snRNP, and Sm showed a speckled nuclear staining 
pattern in acinic cells of both SS and non-SS patients, 
as expected.
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Figure 3. Staining pattern and localization of SS-B/La in the acinic 
cells of the LSG of SS patients. A, A speckled nucleoplasmic 
staining pattern of SS-B/La is apparent in the acinic cells of an SS 
patient, using MAb SW5. B, Arrow points to an acinic cell which 
exhibits that cytoplasm is stained while the nucleus is negative. 
(Original magnification x 1,000.) See Figure 1 for definitions.
was also positive (Table 2). The nuclear staining 
patterns of SS-B/La in the acinic cells of both the 
exocrine pancreas and the LSGs of non-SS patients 
were the same, i.e., positive staining of the nucleoli
and no or very weak staining of the nucleoplasm.
0  & .
Using normal human liver tissue, comparison of 
the staining results with MAb SW5 and with biotiny- 
lated, affinity-purified human antibody against SS- 
B/La revealed an intense immunostaining of the nucleo­
plasm of the hepatocytes and a higher-intensity 
staining of the nucleoli by both antibodies. In the 
control sections, which were incubated with PBS 
instead of the biotinylated human anti-SS-B/La anti­
body, no nuclear staining was observed, while the 
cytoplasm of the hepatocytes remained positive due to 
the presence of endogenous biotin in the cytoplasm.
DISCUSSION
The present study demonstrates for the first 
time that in both primary and secondary SS, there is a 
nucleoplasmic accumulation of SS-B/La in the major­
ity of acinic cells and a redistribution of SS-B/La from 
the nucleus to the cytoplasm in acinic cells of the 
LSGs. The presence of this aberrant distribution pat­
tern of SS-B/La in 2 patients with primary SS without 
xerostomia and KCS, and the absence of such a 
pattern in non-SS patients with xerostomia and KCS, 
suggest that the differences between SS and non-SS 
patients are not related to functional activity of the 
acinic cells.
In vitro studies have revealed that in virally or
which is suggestive of secondary SS. These patients 
had normal percentages of IgA-containing plasma cells 
(>70) and normal DF scores (>-2), as well as a normal 
SS-B/La expression pattern in the acinic cells. In 
contrast, the 2 RA patients with SS (patients 4 and 5) 
combined abnormal immunohistologic findings (% IgA 
<70 and DF <-2) with an aberrant expression pattern 
of SS-B/La in the acinic cells. All patients with an 
aberrant SS-B/La expression pattern had an abnormal 
composition of the plasmacellular infiltrate in the
LSGs (% IgA <70 and/or DF <-2) (Table 1).
i
In the normal tissues obtained at autopsy, there 
was inter-organ variation in SS-B/La expression (Ta­
ble 2). SS-B/La was found exclusively in the nuclei. In 
almost all tissues, the nucleoli were stained and the 
intensity of the nucleolar staining appeared to be tissue 
dependent (Table 2). In most tissues, the nucleoplasm
Table 2. Nuclear localization and intensity of immunostaining of 
the SS-B/La antigen in human tissues, using mouse monoclonal 
antibody SW5*
Tissue Nucleoplasm Nucleolus
Liver
Hepatocytes + m|^  «|m
Bile ducts _ +
Spleen + n |im mjai
Lymph node + +• +
Adrenal gland M*|— + +
Pancreas
Exocrine - +
Endocrine + —
Intestinal epithelium + +
Striated muscle + +
Smooth muscle -f +
Endothelium + +
Fibroblasts - +
* + = postively stained; + + = more intensely stained; — = not or 
very weakly stained.
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otherwise transformed cells, an up to 13-fold incre­
mental increase of the nuclear SS-B/La concentration 
and a redistribution of SS-B/La, leading to cyto­
plasmic and cell membrane localizations, could be 
observed (30,31). In an immunofluorescence study 
using MAb SW5, it was shown that infection with 
cytomegalovirus, Epstein-Barr virus, and adenovirus 
was associated with a redistribution of SS-B/La from 
the nucleus to the cytoplasm of the HEp-2 cells, 
whereas cell membrane staining was observed only in 
the adenovirus-infected cells (30). These results could 
be partly reproduced in another study using adenovirus- 
infected HeLa cells and the same antibody against 
SS-B/La, but neither the membrane localization of 
SS-B/La nor an increase in the amount of total SS- 
B/La could be confirmed (32). Redistribution of SS- 
B/La was also observed in poliovirus-infected HeLa 
cells, and it was shown that it did not reflect a leakage 
of nuclear proteins to the cytoplasm (33).
Recently, translocation of SS-B/La to the cyto­
plasm was found in cultured epithelial cells of the 
LSGs of SS and non-SS patients, and it was shown 
that the fraction of cells with cytoplamic SS-B/La 
increased after treatment with interferon-y (34). Redis­
tribution of SS-B/La was more frequently observed in 
SS than in non-SS patients, and the proportion of cells 
with cytoplasmic SS-B/La was greater in SS than in 
non-SS patients (34). An increase of cytoplasmic SS- 
B/La was also observed in proliferating peripheral 
blood lymphocytes after stimulation with phytohem­
agglutinin (20). In synchronized cells, it was shown 
that in the G0 phase of the cell cycle, SS-B/La was 
nucleoplasmic in location, but during the G1 and early 
S phases, strong immunostaining was found in the 
nucleoli. This pattern changed into a nucleoplasmic 
staining during the late S and G2 phases of the cell 
cycle (4). In SS and non-SS patients, most acinic cells 
are in the G0 phase, as we have shown by use of 
monoclonal antibody MIB1 (35), which recognizes the 
cell proliferation-associated Ki-67 antigen (which is 
expressed during the G,, S, and G2/M phases, but not 
in the G0 phase) (data not shown). Therefore, the 
aberrant immunostaining pattern of SS-B/La in the 
majority of acinic cells in SS cannot be explained by 
differences in cell proliferation.
Cytoplasmic and membrane localization of SS- 
B/La has been reported in the epithelial cells of the 
conjunctiva of SS, KCS, and viral conjunctivitis pa­
tients, while in control subjects, a weak nuclear ex­
pression of SS-B/La was observed (36). Our observa­
tions suggest that redistribution also seems to occur in
the LSG acinic cells of SS patients. The latter phe­
nomenon cannot be explained by a diffusion artefact, 
since cytoplasmic localization of SS-B/La was not 
observed in normal liver, spleen, and adrenal cells, 
which also showed high nuclear SS-B/La immuno- 
reactivity. U1 snRNP, U2 snRNP, and Sm did not 
exhibit such enhanced nuclear immunoreactivity or 
cytoplasmic localization in the acinic cells of the LSGs 
of SS patients, and differences between SS and non-SS 
patients were not observed. The absence of redistri­
bution of Sm from the nucleus to the cytoplasm was 
also found in the experiments of Baboonian et al with 
virally infected cells (30). Cytoplasmic and cell mem­
brane localization of snRNPs, Sm, SS-B/La, and SS- 
A/Ro has been described in cell lines after ultraviolet 
(UV) irradiation (32). This extranuclear localization 
may be caused by UV irradiation-induced apoptosis, 
because it has been shown that apoptotic bodies 
contain nucleosomal DNA, SS-A/Ro, SS-B/La, and 
snRNPs (37).
Although MAb 2G10, directed against SS-A/ 
Ro, is suboptimal for immunohistochemical purposes, 
it is obvious that the differences in the expression 
patterns of SS-A/Ro between SS and non-SS patients 
are not as convincing as for SS-B/La. Studies with 
more suitable MAb directed against SS-A/Ro are nec­
essary to confirm our observations. A possible expla­
nation for the differences in the expression patterns of 
SS-B/La and SS-A/Ro is that the latter forms com­
plexes only with hY RNAs, whereas SS-B/La can be 
complexed with all cellular RNA polymerase III tran­
scripts, including the hY RNAs, as well as with several 
viral transcripts (1,2). Viruses, especially the Epstein- 
Barr virus and retroviruses, have been suspected to be 
major contributing factors in the etiology of SS (38-40).
Recently, we found a 45% prevalence of grade 
IV lymphocytic adenitis in the LSGs of RA patients 
who had no clinical evidence of SS and no immuno- 
histologic abnormalities, as defined by a DF score <-2 
and/or % IgA-containing plasma cells <70 (14). Al­
though RA patients with a grade IV adenitis should be 
diagnosed as having secondary SS according to the 
criteria of Daniels and Talal (16), it seemed unlikely 
that our RA patients had SS, because of the absence of 
clinical and disease-specific immunohistologic features 
of SS in the LSG biopsy samples. The absence of the 
aforementioned abnormalities in the plasma cell com­
position prompted us to conclude that the focal lym­
phocytic adenitis in RA patients without SS is based 
on a different pathophysiologic mechanism, compared 
with the same type of LSG adenitis in SS patients (14).
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The normal SS-B/La expression in the LSGs of these 
RA patients and the aberrant SS-B/La expression in 
RA patients with SS gives further support to this 
hypothesis.
The aberrant nuclear and cytoplasmic distribu­
tion of SS-B/La found in the LSG tissue of SS patients, 
together with the local production and secretion of 
anti-SS-B/La (10), support the hypothesis that mem­
brane localization of SS-B/La might provoke the local 
SS-B/La antigen-driven immune response. Although 
the cause of the aberrant SS-B/La expression pattern 
in acinic cells in SS patients remains to be elucidated, 
and the cell membrane localization should be con­
firmed by more informative techniques, such as ultra- 
structural immunohistochemical procedures, it seems 
likely that the nuclear accumulation and redistribution 
of SS-B/La in the acinic cells plays a role in the 
pathogenesis of the B cell hyperreactivity and chronic 
lymphocytic adenitis of the salivary glands of SS 
patients. In addition, the consistently enhanced nu­
clear immunostaining of SS-B/La in acinic cells seems 
to be a promising tool to improve the diagnosis of SS 
in the LSG biopsy.
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